BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15255235)

  • 1. Long-term effect of plasmin on the vitreolysis in rabbit eyes.
    Kim NJ; Yu HG; Yu YS; Chung H
    Korean J Ophthalmol; 2004 Jun; 18(1):35-40. PubMed ID: 15255235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes.
    Sakuma T; Tanaka M; Mizota A; Inoue J; Pakola S
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3295-9. PubMed ID: 16123432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy.
    Gandorfer A; Putz E; Welge-Lüssen U; Grüterich M; Ulbig M; Kampik A
    Br J Ophthalmol; 2001 Jan; 85(1):6-10. PubMed ID: 11133703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
    Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic vitreolysis with plasmin and hyaluronidase in diabetic rats.
    Zhi-Liang W; Wo-Dong S; Min L; Xiao-Ping B; Jin J
    Retina; 2009 Feb; 29(2):269-74. PubMed ID: 19050667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic induction of posterior vitreous detachment in the rabbit.
    Verstraeten TC; Chapman C; Hartzer M; Winkler BS; Trese MT; Williams GA
    Arch Ophthalmol; 1993 Jun; 111(6):849-54. PubMed ID: 8512489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy.
    Wang ZL; Zhang X; Xu X; Sun XD; Wang F
    Retina; 2005 Jan; 25(1):38-43. PubMed ID: 15655439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior vitreous detachment with plasmin in the isolated human eye.
    Li X; Shi X; Fan J
    Graefes Arch Clin Exp Ophthalmol; 2002 Jan; 240(1):56-62. PubMed ID: 11954782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety profile of the intravitreal streptokinase-plasmin complex as an adjunct to vitrectomy in the rabbit.
    Hermel M; Mahgoub M; Youssef T; Azrak MI; Raza H; Alldredge C; Trese M; Williams GA; Hartzer M
    Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):996-1002. PubMed ID: 16365737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior vitreous detachment induced by nattokinase (subtilisin NAT): a novel enzyme for pharmacologic vitreolysis.
    Takano A; Hirata A; Ogasawara K; Sagara N; Inomata Y; Kawaji T; Tanihara H
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2075-9. PubMed ID: 16639018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient vitreolysis by combining plasmin and sulfur hexafluoride injection in a preclinical study in rabbit eyes.
    Wu WC; Liu CH; Chen CC; Wang NK; Chen KJ; Chen TL; Hwang YS; Li LM; Lai CC
    Mol Vis; 2012; 18():2361-70. PubMed ID: 23049236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of plasmin enzymes and chondroitinase ABC in creating posterior vitreous separation in the pig: a masked, placebo-controlled in vivo study.
    Hermel M; Schrage NF
    Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):399-406. PubMed ID: 16900357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis.
    Wang F; Wang Z; Sun X; Wang F; Xu X; Zhang X
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3286-90. PubMed ID: 15326153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmin treatment accelerates vascular endothelial growth factor clearance from rabbit eyes.
    Wu WC; Chen CC; Liu CH; Wang NK; Chen KJ; Chen TL; Hwang YS; Li LM; Lai CC
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6162-7. PubMed ID: 21245395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Assessment of Pharmacologic Vitreolysis in Rabbits With the Digital Fluoroscopy System.
    Bae JH; Park HS; Kim JM; Lee BR; Lee SC; Tandogan T; Auffarth GU; Koss MJ; Choi CY
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4817-22. PubMed ID: 26218910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreoretinal morphology of plasmin-treated human eyes.
    Gandorfer A; Priglinger S; Schebitz K; Hoops J; Ulbig M; Ruckhofer J; Grabner G; Kampik A
    Am J Ophthalmol; 2002 Jan; 133(1):156-9. PubMed ID: 11755861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous.
    Hikichi T; Yanagiya N; Kado M; Akiba J; Yoshida A
    Retina; 1999; 19(1):55-8. PubMed ID: 10048374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment.
    Unal M; Peyman GA
    Retina; 2000; 20(1):69-75. PubMed ID: 10696751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A disposable system for rapid purification of autologous plasmin as an adjunct to vitrectomy - performance and safety profile.
    Hermel M; Dailey W; Trese M; Hartzer MK
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):37-46. PubMed ID: 20680641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiment of vitreous liquefaction induced by C3F8.
    Wang J; Li Q
    Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):281-287. PubMed ID: 28625955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.